Difficulty: Medium
Average Score: 95%
Practice
A client at 32 weeks' gestation is experiencing preterm labor. What is the primary goal of tocolytic therapy?
Correct answer
B
Rationale
In the context of pharmacology in maternal newborn nursing, the primary goal of tocolytic therapy in a client experiencing preterm labor at 32 weeks' gestation is to delay delivery and improve fetal lung maturity (Option B). Tocolytic agents are used to inhibit uterine contractions temporarily, allowing time for corticosteroids to enhance fetal lung development and for the administration of magnesium sulfate for neuroprotection in the preterm neonate.
Option A, to prevent fetal hypoxia, is not the primary goal of tocolytic therapy. While delaying delivery can indirectly contribute to reducing fetal hypoxia by allowing time for appropriate interventions, it is not the direct aim of tocolysis.
Option C, to reduce maternal blood pressure, is not typically a primary goal of tocolytic therapy. Tocolytic agents primarily target uterine smooth muscle to delay labor and do not have a direct effect on maternal blood pressure.
Option D, to increase uteroplacental blood flow, is not the primary goal of tocolytic therapy. While maintaining adequate uteroplacental perfusion is important in pregnancy, tocolytic therapy is specifically aimed at inhibiting uterine contractions to delay preterm labor and its associated risks.
Understanding the rationale behind tocolytic therapy is crucial for nurses caring for pregnant individuals at risk for preterm labor. By delaying delivery, healthcare providers can optimize outcomes for both the mother and the preterm neonate, emphasizing the importance of fetal lung maturity and appropriate interventions before birth.
Option A, to prevent fetal hypoxia, is not the primary goal of tocolytic therapy. While delaying delivery can indirectly contribute to reducing fetal hypoxia by allowing time for appropriate interventions, it is not the direct aim of tocolysis.
Option C, to reduce maternal blood pressure, is not typically a primary goal of tocolytic therapy. Tocolytic agents primarily target uterine smooth muscle to delay labor and do not have a direct effect on maternal blood pressure.
Option D, to increase uteroplacental blood flow, is not the primary goal of tocolytic therapy. While maintaining adequate uteroplacental perfusion is important in pregnancy, tocolytic therapy is specifically aimed at inhibiting uterine contractions to delay preterm labor and its associated risks.
Understanding the rationale behind tocolytic therapy is crucial for nurses caring for pregnant individuals at risk for preterm labor. By delaying delivery, healthcare providers can optimize outcomes for both the mother and the preterm neonate, emphasizing the importance of fetal lung maturity and appropriate interventions before birth.